Ending Marijuana Prohibition in 2013

Rob Kampia

Executive director, Marijuana Policy Project

 

Unless people have been hiding under a rock this past couple months, they know that more than 55 percent of voters in Colorado and Washington legalized marijuana on November 6. As a result, many people have grand expectations of how we’re going to get closer to ending marijuana prohibition in the U.S. this year.

Here is what I think we can reasonably accomplish by the end of 2013:

1. Decriminalize Marijuana in Vermont: Gov. Pete Shumlin (D), a strong supporter of decriminalizing marijuana, partially campaigned on the issue and easily won re-election on November 6 with 58% of the vote. The Vermont Llegislature is poised to pass the bill he wants, so this legislation could become law by this summer.

2. Legalize Medical Marijuana in New Hampshire: Incoming Gov. Maggie Hassan (D) is a strong supporter of medical marijuana, so we expect her to sign a medical marijuana bill similar to those vetoed by former Gov. John Lynch (D) in 2009 and 2012.

3. Build Support for Legalization in the Rhode Island Legislature:
We successfully legalized medical marijuana and decriminalized marijuana possession in Rhode Island in 2009 and 2012, respectively. There is now considerable momentum to tax and regulate (T&R) marijuana like alcohol, so we need to ensure that Rhode Island’s state legislature becomes the first to do so.

4. Increase Support for Legalization in California, Maine, and Oregon: There will be a sincere effort to pass T&R bills through the legislatures in these three states. Should they fall short, MPP and its allies will pursue statewide ballot initiatives in November 2016, at which time all three will be expected to pass.

5. Build Our Base of Support Online: People have said that the Internet is marijuana legalization’s best friend, and this could not have been more evident than it was last year. Campaigns mobilized their supporters, organizations raised funds, and the public was able to follow the progress in real time. Prohibitionists, who have depended on the government for its largess for years, are now at a disadvantage. Private citizens simply do not want to donate to them, and most information about marijuana is now reaching the public without being run through their filter.

6. Continue the Steady Drumbeat in the Media:
National and local media outlets are covering the marijuana issue more than ever before. Communicating to voters through news coverage is the most cost-efficient way to increase public support for ending marijuana prohibition, so we need to keep the issue in the spotlight.

7. Build Support for Medical Marijuana in Congress: There are already approximately 185 members of the U.S. House who want to stop the U.S. Justice Department from spending taxpayer money on raiding medical marijuana businesses in the 18 states (and DC) where medical marijuana is legal. We want to reach 218 votes on this amendment, thereby ensuring the amendment’s transfer to the U.S. Senate for an up-or-down vote.

8. Build Support for Ending Marijuana Prohibition in Congress: Last year, the first-ever bill to end the federal government’s prohibition of marijuana attracted 21 sponsors. Our goal is to expand the number of sponsors to more than two-dozen during the 2013-2014 election season.

Looking outside our borders, we’re also seeing progress in Colombia, Uruguay, and Chile, which have all been steadily moving away from marijuana prohibition. Although this is good news, most members of the U.S. Congress do not care much about what South American countries think on marijuana policy, so we should temper the wonderful developments south of the U.S. border with limited expectations of what will happen in our nation’s capital.

Ultimately, the U.S. is the primary exporter of prohibition around the world. If we can solve the problem here, the rest of the world will have far more freedom to conduct their own experiments with regulating marijuana.

FOLLOW POLITICS

Advertisements

Ode to the Hemp

A PRAYER TO OUR CREATOR

Richard and his plant

WE COME TOGETHER TODAY TO PRAISE YOUR ALMIGHTY
GIFTS TO US…

YOU HAVE GIVEN US LIGHT FOR WARMTH,
MEADOWS OF FRESH FLOWERS,
AND HERBS,TO KEEP UP HEALTHY,
YOU GAVE US DARK TO SLEEP AND TO REST OUR
WEARY HEARTS AND MINDS FOR ANOTHER DAY,
YOU GAVE US BROTHERS AND SISTERS TO LOVE US,
AND CHILDREN TO CARRY ON OUR NEVER-ENDING
ENDEAVORS – TO CARRY OUT YOUR WILL ,
AS WE KNOW WE WILL NEVER ACCOMPLISH
THIS ALONE.

YOU GIVE US INTELLIGENCE TO BE ABLE TO
SEPARATE THE GOOD FROM THE EVIL,
DEAR FATHER IN HEAVEN,
GIVE US THIS DAY, OUR DAILY BREAD,
AND FORGIVE US OUR SINS,
AS WE FORGIVE ALL OTHERS,

AND

GIVE US THE STRENGTH, TO CARRY ON,
TO RECTIFY THE EVIL THAT TO WHICH WE HAVE
SUCCUMB,
TO BRING BACK THE MEADOWS,
THE FLOWERS AND TREE’S,
TO CONTINUE TO HEAR THE BIRD’S AND BEE’S!
BLESS THE HEMP LORD, AND KEEP IT STRONG,
AND ENABLE US, TO CARRY ON…

AMEN

@ShereeKrider

*Dedicated with Love to Richard J. Rawlings…USMJParty

Study casts doubt on link between cannabis, teen IQ drop

Wednesday, January 23, 2013

Related MedlinePlus Pages

SYDNEY (Reuters) – A landmark study suggesting a link between cannabis use and a drop in teenage IQ may not have gone far enough in its research, with any falls in IQ more likely due to lower socioeconomic status than marijuana, according to a Norwegian study.

The latest work, which appears in the journal PNAS, Proceedings of the National Academy of Sciences of the United States of America, also suggests that different policy steps might be needed in that case.

"My study essentially shows that the methods used and analyses presented in the original research are insufficient to rule out other explanations (for lower IQ)," said Ole Rogeberg, an economist at the Frisch Centre for Economics Research in Oslo, to Reuters.

The Dunedin Multi-disciplinary Health and Development Study is an ongoing report produced by New Zealand’s University of Otago, monitoring 1,037 New Zealand children born between April 1972 and March 1973. The study followed them for 40 years.

The participants were periodically tested for IQ and other indices including drug taking, and in 2012 clinical psychologist Madeline Meier produced a study saying there was a link between teenage cannabis use and a lower IQ.

Researchers in the Meier study compared the IQ trends of people who never smoked cannabis with four groups of those who did: people who smoked, people who scored as dependent in a follow-up survey, those who scored as dependent twice and those who scored as dependent three times.

The study found IQ declines increasing "linearly" with cannabis use, Rogeberg wrote in PNAS.

The crucial assumption in the Meier study is that cannabis use is the only relevant difference between the groups tested, he said. His use of a simulation model showed that it may be premature to draw a causal inference between marijuana use and falling IQ scores.

For one thing, other writing about the Dunedin group on which Meier’s study is based suggest that early cannabis use is more common for people with poor self-control, previous conduct problems, and high scores on risk factors linked to low family socioeconomic status, he wrote.

Given these factors, young people from lower status families tended to end up in less intellectually demanding environments, whether by choice or by circumstance, which would increase the difference in IQ levels as they aged.

"We know that the researchers have measured the IQ of the participants at various ages in childhood – but we don’t know if the IQ changes were similar for the different cannabis-using groups before their cannabis use," he told Reuters.

"We don’t know how much of the change in IQ we can explain by differences in education, jail time, occupational status, etc and whether this affects the estimates in the paper."

(Reporting by Pauline Askin, editing by Elaine Lies)

Reuters Health

CONTINUE…

Medical marijuana backers lose bid for looser regulations

By Tom Schoenberg, © 2013, Bloomberg News

 

WASHINGTON — An appeals court rejected the bid by medical marijuana backers to ease federal controls of the drug, ruling that the government properly kept the substance in its most dangerous category.

A three-judge panel of the U.S. Court of Appeals on Tuesday upheld the Drug Enforcement Administration’s decision to maintain marijuana as a Schedule I drug under the Controlled Substances Act because there are no adequate scientific studies finding an acceptable medical use.

"The question before the court is not whether marijuana could have some medical benefits," U.S. Circuit Judge Harry Edwards wrote in the opinion.

Edwards said the court’s review was limited to whether the DEA’s decision declining to reschedule the drug was arbitrary and capricious. He said the court found there was "substantial evidence" to support the agency’s determination that such studies don’t exist.

The case involves a 10-year-old petition from medical marijuana advocates who asked the DEA to reclassify marijuana as a Schedule III, IV or V drug, which would allow for looser regulation. On June 21, 2011, the DEA rejected the request, stating that existing clinical evidence wasn’t adequate to warrant reclassification.

"To deny that sufficient evidence is lacking on the medical efficacy of marijuana is to ignore a mountain of well- documented studies that conclude otherwise," Joe Elford, chief counsel with Americans for Safe Access, the medical marijuana advocacy


hemp-300x200


organization that brought the case, said in an e-mailed statement.

Elford told the court during arguments in October that there were more than 200 studies that the agency refused to consider.

The group said it will appeal the ruling, according to the statement.

Lena Watkins, a lawyer for the Justice Department, told the court in October that the studies cited by the marijuana proponents were rejected because the research didn’t meet government standards. She said about 15 studies meet the standards, though the government doesn’t have the final results yet.

The court also waved off claims that government blocked efforts to study the medical effects of marijuana, citing the Health and Human Services Department policy supporting the clinical research with botanical marijuana.

"It appears that adequate and well-controlled studies are wanting not because they have been foreclosed but because they have not been completed," Edwards said in the ruling.

CONTINUE READING…

Studying Marijuana and Its Loftier Purpose

Tikkun Olam, a medical marijuana farm in Israel, blends the high-tech and the spiritual.

By ISABEL KERSHNER
Published: January 1, 2013

 

SAFED, Israel — Among the rows of plants growing at a government-approved medical marijuana farm in the Galilee hills in northern Israel, one strain is said to have the strongest psychoactive effect of any cannabis in the world. Another, rich in anti-inflammatory properties, will not get you high at all.

Marijuana is illegal in Israel, but farms like this one, at a secret location near the city of Safed, are at the cutting edge of the debate on the legality, benefits and risks of medicinal cannabis. Its staff members wear white lab coats, its growing facilities are fitted with state-of-the-art equipment for controlling light and humidity, and its grounds are protected by security cameras and guards.

But in addition to the high-tech atmosphere, there is a spiritual one. The plantation, Israel’s largest and most established medical marijuana farm — and now a thriving commercial enterprise — is imbued with a higher sense of purpose, reflected by the aura of Safed, an age-old center of Jewish mysticism, as well as by its name, Tikkun Olam, a reference to the Jewish concept of repairing or healing the world.

There is an on-site synagogue in a trailer, a sweet aroma of freshly harvested cannabis that infuses the atmosphere and, halfway up a wooded hillside overlooking the farm, a blue-domed tomb of a rabbinic sage and his wife.

In the United States, medical marijuana programs exist in 18 states but remain illegal under federal law. In Israel, the law defines marijuana as an illegal and dangerous drug, and there is still no legislation regulating its use for medicinal purposes.

Yet Israel’s Ministry of Health issues special licenses that allow thousands of patients to receive medical marijuana, and some government officials are now promoting the country’s advances in the field as an example of its pioneering and innovation.

“I hope we will overcome the legal obstacles for Tikkun Olam and other companies,” Yuli Edelstein, the minister of public diplomacy and diaspora affairs, told journalists during a recent government-sponsored tour of the farm, part of Israel’s effort to brand itself as something beyond a conflict zone. In addition to helping the sick, he said, the effort “could be helpful for explaining what we are about in this country.”

Israelis have been at the vanguard of research into the medicinal properties of cannabis for decades.

In the 1960s, Prof. Raphael Mechoulam and his colleague Yechiel Gaoni at the Weizmann Institute of Science isolated, analyzed and synthesized the main psychoactive ingredient in the cannabis plant, tetrahydrocannabinol, or THC. Later, Professor Mechoulam deciphered the cannabinoids native to the brain. Ruth Gallily, a professor emerita of immunology at the Hebrew University of Jerusalem, has studied another main constituent of cannabis — cannabidiol, or CBD — considered a powerful anti-inflammatory and anti-anxiety agent.

When Zach Klein, a former filmmaker, made a documentary on medical marijuana that was broadcast on Israeli television in 2009, about 400 Israelis were licensed to receive the substance. Today, the number has risen to about 11,000.

Mr. Klein became devoted to the subject and went to work for Tikkun Olam in research and development. “Cannabis was used as medicine for centuries,” he said. “Now science is telling us how it works.”

Israeli researchers say cannabis can be beneficial for a variety of illnesses and conditions, from helping cancer patients relieve pain and ease loss of appetite to improving the quality of life for people with post-traumatic stress disorder and neuropsychological conditions. The natural ingredients in the plant, they say, can help with digestive function, infections and recovery after a heart attack.

The marijuana harvest, from plants that can grow over six feet tall, is processed into bags of flowers and ready-rolled cigarettes. There are also cannabis-laced cakes, cookies, candy, gum, honey, ointments and oil drops. The strain known as Eran Almog, which has the highest concentration of THC, is recommended for severe pain. Avidekel, a strain rich in CBD and with hardly any psychoactive ingredient, allows patients to benefit from the drug while being able to drive and to function at work.

Working with Hebrew University researchers, the farm has also developed a version in capsule form, which would make exporting the drug more practical, should the law allow it.

CONTINUE READING PAGE 2….

White House: “We’re in the Midst of a Serious National Conversation on Marijuana”

by Erik Altieri, NORML Communications Director January 8, 2013

 

 

Ohhhh So Beautiful

In October of 2011, the White House issued an official response to a petition NORML submitted via their We the People outreach program on the topic of marijuana legalization.

 

Despite being one of the most popular petitions at the site’s launch, the answer we received was far from satisfactory. Penned by Drug Czar Gil Kerlikowske, the response featured most of the typical government talking points. He stated that marijuana is associated with addiction, respiratory disease, and cognitive impairment and that its use is a concern to public health. “We also recognize,” Gil wrote, “that legalizing marijuana would not provide the answer to any of the health, social, youth education, criminal justice, and community quality of life challenges associated with drug use.”

Well, just over a year later, the White House has responded again to a petition to deschedule marijuana and legalize it. The tone this time is markedly different, despite being penned by the same man.

Addressing the Legalization of Marijuana
By Gil Kerlikowske

Thank you for participating in We the People and speaking out on the legalization of marijuana. Coming out of the recent election, it is clear that we’re in the midst of a serious national conversation about marijuana.

At President Obama’s request, the Justice Department is reviewing the legalization initiatives passed in Colorado and Washington, given differences between state and federal law. In the meantime, please see a recent interview with Barbara Walters in which President Obama addressed the legalization of marijuana.

Barbara Walters:

Do you think that marijuana should be legalized?

President Obama:

Well, I wouldn’t go that far. But what I think is that, at this point, Washington and Colorado, you’ve seen the voters speak on this issue. And as it is, the federal government has a lot to do when it comes to criminal prosecutions. It does not make sense from a prioritization point of view for us to focus on recreational drug users in a state that has already said that under state law that’s legal.

…this is a tough problem because Congress has not yet changed the law. I head up the executive branch; we’re supposed to be carrying out laws. And so what we’re going to need to have is a conversation about how do you reconcile a federal law that still says marijuana is a federal offense and state laws that say that it’s legal.

When you’re talking about drug kingpins, folks involved with violence, people are who are peddling hard drugs to our kids in our neighborhoods that are devastated, there is no doubt that we need to go after those folks hard… it makes sense for us to look at how we can make sure that our kids are discouraged from using drugs and engaging in substance abuse generally. There is more work we can do on the public health side and the treatment side.

Gil Kerlikowske is Director of the Office of National Drug Control Policy

No tirade about protecting our children. No alarmist claims about sky rocketing marijuana potency and devastating addiction potential. Just a few short paragraphs stating we are “in the midst of a serious national conversation about marijuana” and deferring to an interview with the President where he stated arresting marijuana users wasn’t a priority and that the laws were still being reviewed. While far from embracing an end to marijuana prohibition, the simple fact that America’s Drug Czar had the opportunity to spout more anti-marijuana rhetoric and instead declined (while giving credence to the issue by stating it is a serious national conversation) it’s at the very least incredibly refreshing, if not a bit aberrational. We can only hope that when the administration finishes “reviewing” the laws just approved by resounding margins in Washington and Colorado, they choose to stand with the American people and place themselves on the right side of history.

“We the People” are already there.

CONTINUE READING….

With this post I am effectively taking a ‘sabbatical’ from updating online…

 

 

I look like im crying

All of you that know me also know what I and Richard have been going through for the last year and a half.

As well, all his family and friends and mine also have suffered through this past year.

I have come to a point where I feel it is best to retreat from what I usually do and focus on my

life at hand at this moment.

 

As this point everyone already knows that Richard isn’t getting any better.  I won’t go

any further than that at this point but I will have someone to post updates when they are

specifically needed onto Facebook.

I myself am  suffering from depression as well as physical problems and am not functioning well

at all.

In short – I am exhausted both mentally and physically.  And most certainly

Richard is too.

I will be in touch with Bill Chengelis, Rev. Mary Spears and Henry Fox who I’m sure will take

on the task of posting the important things I tell them.

I suppose that is all there is to say at this point except I appreciate all the prayers, notes of kindness

and support I’ve gotten from all of you.

I hope at some point I will be back.  I’m sure (I hope) I will still post once in a while but for now

it will be up to someone else to do the “searching for the newsworthy items to post”.

If anyone needs help getting signed onto the http://kentuckymarijuanaparty.wordpress.com site,

or any others let me know and I will help out with that.

KEEP THE GOOD FIGHT GOING ….  DON’T LET OUR GOVERNMENT SHUT US UP ONE PERSON AT A TIME!

WHEN ONE IS DOWN, ANOTHER MUST COME UP AND TAKE THE SLACK – AS I DID WHEN I FIRST STARTED ON

THE OLD USMJPARTY.ORG OF KENTUCKY SITE. 

Anyway, I love you all and please keep the prayers coming – we need them.

Peace to Everyone,

Sheree Krider

Jan 7, 2013

shereekrider@hotmail.com

Patrick Kennedy On Marijuana: Former Rep. Leads Campaign Against Legal Pot

Reuters  |  Posted: 01/05/2013 2:11 pm EST

By Alex Dobuzinskis

 

Jan 5 (Reuters) – Retired Rhode Island Congressman Patrick Kennedy is taking aim at what he sees as knee-jerk support for marijuana legalization among his fellow liberals, in a project that carries special meaning for the self-confessed former Oxycontin addict.

Kennedy, 45, a Democrat and younger son of the late "Lion of the Senate" Edward M. Kennedy of Massachusetts, is leading a group called Project SAM (Smart Approaches to Marijuana) that opposes legalization and seeks to rise above America’s culture war over pot with its images of long-haired hippies battling law-and-order conservatives.


Project proposals include increased funding for mental health courts and treatment of drug dependency, so those caught using marijuana might avoid incarceration, get help and potentially have their criminal records cleared.

Kennedy wants cancer patients and others with serious illnesses to be able to obtain drugs with cannabinoids, but in a more regulated way that could involve the U.S. Food and Drug Administration playing a larger role.

The eight-term former congressman from Rhode Island and the group he chairs will put forth their plan on Wednesday with a media appearance in Denver.
Their efforts follow the November election that saw voters in Washington state and Colorado become the first in the nation to approve measures to tax and regulate pot sales for recreational use. Kennedy’s group is seeking to shift the debate and reclaim momentum for the anti-legalization movement, in part by proposing new solutions with appeal to liberals, such as taking a public health approach to combat marijuana use.

Legalization backers have argued that the so-called War on Drugs launched in 1971 by former President Richard Nixon has failed to stem marijuana use, and has instead saddled otherwise law-abiding pot smokers with criminal records that may block their avenues to landing a successful job.
Kennedy faults the U.S. government for allocating too much of its $25 billion drug control budget to law enforcement rather than to treatment and prevention.
"Yes, the drug war has been a failure, but let’s look at the science and let’s look at what works. And let’s not just throw out the baby with the bathwater," Kennedy, who served in the U.S. House of Representatives from 1995 to 2011, said in a telephone interview.

The U.S. Department of Justice is still developing a policy in regard to the new state legalization measures.

President Barack Obama said in an interview with ABC News last month that it did not make sense for the federal government to "focus on recreational drug users in a state that has already said that, under state law, that’s legal."

BIPARTISAN APPROACH

 

Conservative political commentator David Frum, a speech writer for former President George W. Bush, is also a board member on Project SAM, which lends it a bipartisan flavor.
For his part, Kennedy is aiming many of his arguments toward liberals like himself. Polls show Democrats largely favoring legalizing marijuana, and among the 18 states that allow medical marijuana, several are in the West and Northeast and are heavily Democratic.

"The fact is people are afraid on the (political) left to look like they’re not for an alternative to incarceration and criminalization, and they’re afraid they’re not going to look sympathetic to a cancer patient" who might use marijuana, Kennedy said. As a result, he said the legalization position mistakenly comes to be seen as "glamorous."

Kennedy admits to having smoked pot but also said that, as an asthma sufferer, he "found other ways to get high."


In 2006, he crashed his car into a security barrier in Washington, D.C., and soon after sought treatment for drug dependency. He said he was addicted to the pain reliever Oxycontin at that time and suffered from alcoholism. He added that he has been continuously sober for nearly two years.
Kennedy, who was married for the first time in 2011, said he worries his 8-month-old son might be predisposed to drug abuse – due to a kind of genetic "trigger" – and that is part of his fight against legalization.

He also said he wants to "reduce the environmental factors that pull that trigger," such as marijuana use being commonly accepted.
Meanwhile, another prominent figure from Rhode Island, the newly crowned Miss Universe Olivia Culpo, is making waves by also objecting to legalization. She told Fox News this week there are "too many bad habits that go with the drug."

In Washington state, Alison Holcomb was campaign director for the legalization measure, which billed itself as having a public health element to help people dependent on marijuana.
The measure, which is not set to go into full effect until after state regulators spend most of 2013 setting guidelines, would allow adults 21 and older to buy marijuana at special stores.
Holcomb argued that drug dependency courts are more geared toward users of hardcore drugs, and that the approach her group put forward is the sensible one.
"I don’t know what a public health approach without legalization looks like, if you’re still arresting people," she said.
Taxes on marijuana sales would generate, at the high end of estimates, over $500 million a year with $67 million of that going to a state agency that provides drug treatment, said Mark Cooke, policy adviser for the American Civil Liberties Union of Washington state, which supported the campaign.

Also included in the tax revenue would be $44 million for education and public health campaigns – including a phone line for people wanting to quit using marijuana, Cooke said. (Reporting by Alex Dobuzinskis; Editing by Daniel Trotta and Gunna Dickson)

CONTINUE READING…

From the Mayo Clinic: Cannabis/Marijuana

Marijuana (Cannabis sativa)

en2661297

 

Evidence

These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.

Chronic pain

Cannabinoids have been reported to reduce chronic pain associated with a variety of conditions. Cannabinoids have also been used in patients for whom other pain relief medications are not working. The active components in cannabis exert their effects on the central nervous system and immune cells. Cannabis is approved in some European countries and Canada. In the United States, it is an investigational drug for pain relief in cancer patients.
A

Multiple sclerosis (symptoms)

Research suggests that cannabinoids may improve some symptoms associated with multiple sclerosis (MS), specifically neuropathic pain, muscle spasms, and urinary symptoms.
A

Eczema

Early studies suggest that taking hemp seed oil by mouth may reduce symptoms of eczema, a skin rash also referred to as atopic dermatitis. Additional research is needed before a conclusion can be made.
C

Epilepsy

Early research suggests that epileptic patients may experience fewer seizures when taking cannabidiol (CBD) together with antiseizure medication. Further studies are required before a conclusion can be made.
C

Glaucoma (high fluid pressure inside the eye)

Glaucoma can result in optic nerve damage and blindness. Limited evidence suggests that tetrahydrocannabinol (THC) taken under the tongue may reduce eye pressure. Additional research is needed before a conclusion can be made.
C

Huntington’s disease

Huntington’s disease is a degenerative nerve disorder associated with uncoordinated, jerky body movements and mental deterioration. Early studies suggest that cannabidiol (CBD) may not aid in reducing the severity of uncoordinated body movements associated with Huntington’s disease. Further studies are needed before a firm conclusion can be made.
C

Insomnia

Limited research suggests that cannabidiol may improve sleep quality in those with insomnia (difficulty getting to sleep or staying asleep). More research is needed before a conclusion can be made.
C

Appetite/weight loss in cancer patients

Clinical studies have shown no effect of cannabis-based therapies in the treatment of weight loss associated with cancer. Further studies are necessary before a conclusion can be made.
D

Schizophrenia

In limited research, no effect of cannabidiol (CBD) was seen on symptoms of schizophrenia in patients for whom other treatments were not working. Additional research is needed before a conclusion can be made.
D

Key to grades
A Strong scientific evidence for this use
B Good scientific evidence for this use
C Unclear scientific evidence for this use
D Fair scientific evidence against this use (it may not work)
F Strong scientific evidence against this use (it likely does not work)

 

Uses based on tradition or theory

The below uses are based on tradition or scientific theories. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.

Acne, addiction, allergies, Alzheimer’s disease, angina (chest pain), angioedema (swelling under the skin), arthritis, antiaging, antidepressant, anti-inflammatory, antioxidant, anxiety prevention, appetite stimulant, asthma, attention-deficit hyperactivity disorder (ADHD), autoimmune diseases, bipolar disorder (mental disorder), blood thinner, bronchodilation (widens airways and eases breathing), burns, cancer, candidiasis (yeast infection), circulation improvement, constipation, cough, detoxification (removal of toxins), diabetes, digestive aid, diuretic (improves urine flow), dystonia (muscle disorder), energy metabolism, fatigue, gastric acid secretion stimulation (increases stomach acid), general health maintenance, genitourinary tract disorders (disorders of the reproductive and urinary systems), hair growth promoter, heart disease, high blood pressure, hormone regulation, immune suppression, increased muscle mass, increasing breast milk, inflammatory bowel disease (Crohn’s disease and ulcerative colitis), intermittent claudication (pain in arms or legs due to inadequate oxygen), interstitial cystitis (bladder disorder), irregular heartbeat, leukemia (cancer of blood cells), lipid lowering (cholesterol and triglycerides), liver protection, lymph flow enhancement, menopausal symptoms, migraine, muscle relaxation, nausea and vomiting, nerve disorders, neural tube defects (birth defects), osteoporosis (bone loss), painful menstruation, pregnancy and labor, psychosis, rheumatism (joint disease), sedative, sexual performance, skin conditions, spinal cord injury, stomach spasms, stroke, tendonitis, uterine stimulant, varicose veins, vitamin C deficiency, weight gain (patients with HIV or cancer), wound healing.

 

Dosing

The below doses are based on scientific research, publications, traditional use, or expert opinion. Many herbs and supplements have not been thoroughly tested, and safety and effectiveness may not be proven. Brands may be made differently, with variable ingredients, even within the same brand. The below doses may not apply to all products. You should read product labels, and discuss doses with a qualified healthcare provider before starting therapy.

Adults (18 years and older)

For nausea and vomiting, five milligrams/m 2 of body mass of dronabinol (Marinol®) has been taken by mouth before and after chemotherapy, for a total of 4-6 doses daily.

For weight loss and malnutrition associated with cancer, 2.5 milligrams of tetrahydrocannabinol (THC) with or without one milligram of cannabidiol has been taken by mouth for six weeks.

For eczema, hemp seed oil has been taken by mouth for 20 weeks.

For chronic pain, 2.5-120 milligrams of cannabis has been taken by mouth in divided doses.

For epilepsy, 200-300 milligrams of cannabidiol (CBD) has been taken by mouth daily for up to 4.5 months.

For insomnia, 160 milligrams of cannabidiol (CBD) has been taken by mouth.

For symptoms of multiple sclerosis, 2.5-10 milligrams of dronabinol (Marinol®) has been taken by mouth daily for three weeks. Capsules containing 15-30 milligrams of cannabis extract has been taken by mouth for 14 days. Two and one-half milligrams of tetrahydrocannabinol (THC), together with 0.9 milligrams of cannabidiol (CBD), has been taken by mouth. Cannabinoid-based Sativex® mouth spray has been used at a dose of 2.5-120 milligrams in divided doses. Eight sprays in three hours and up to 48 sprays in 24 hours have been used.

For schizophrenia, 40-1,280 milligrams of cannabidiol (CBD) has been taken by mouth daily for up to four weeks.

For glaucoma (high fluid pressure in the eye), single doses of five milligrams of tetrahydrocannabinol (THC) or 40 milligrams of cannabidiol (CBD) placed under the tongue have been used.

Children (under 18 years old)

There is no proven safe or effective dose for cannabis or cannabis-containing products in children.

CONTINUE READING….